 | • レポートコード：MRC2-11QY12322 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自己免疫疾患用体外診断（IVD）・ラボ開発検査のグローバル市場について調査・分析したレポートです。種類別（試薬・キット、機器、サービス、データ管理ソフトウェア）市場規模、用途別（糖尿病、感染症、腫瘍/癌、心臓病学、腎臓病学、自己免疫疾患、薬物検査、HIV/エイズ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自己免疫疾患用体外診断（IVD）・ラボ開発検査の競争状況、市場シェア ・世界の自己免疫疾患用体外診断（IVD）・ラボ開発検査市場：種類別市場規模 2015年-2020年（試薬・キット、機器、サービス、データ管理ソフトウェア） ・世界の自己免疫疾患用体外診断（IVD）・ラボ開発検査市場：種類別市場規模予測 2021年-2026年（試薬・キット、機器、サービス、データ管理ソフトウェア） ・世界の自己免疫疾患用体外診断（IVD）・ラボ開発検査市場：用途別市場規模 2015年-2020年（糖尿病、感染症、腫瘍/癌、心臓病学、腎臓病学、自己免疫疾患、薬物検査、HIV/エイズ） ・世界の自己免疫疾患用体外診断（IVD）・ラボ開発検査市場：用途別市場規模予測 2021年-2026年（糖尿病、感染症、腫瘍/癌、心臓病学、腎臓病学、自己免疫疾患、薬物検査、HIV/エイズ） ・北米の自己免疫疾患用体外診断（IVD）・ラボ開発検査市場分析：米国、カナダ ・ヨーロッパの自己免疫疾患用体外診断（IVD）・ラボ開発検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自己免疫疾患用体外診断（IVD）・ラボ開発検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自己免疫疾患用体外診断（IVD）・ラボ開発検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自己免疫疾患用体外診断（IVD）・ラボ開発検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Roche Diagnostics、Siemens Healthcare GmbH、SQI Diagnostics、Bio-Rad Laboratories Inc.、Omega Diagnostics Group PLC、Beckton Dickinson & Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases.
The market growth is attributed to rising occurrence of autoimmune diseases & cancers and technological advances in diagnostic techniques.
Market Analysis and Insights: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market
The global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Scope and Market Size
In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Roche Diagnostics
Siemens Healthcare GmbH
SQI Diagnostics
Bio-Rad Laboratories Inc.
Omega Diagnostics Group PLC
Beckton Dickinson & Company
…
Market segment by Type, the product can be split into
Reagents and kits
Instruments
Services
Data management software
Market segment by Application, split into
Diabetes
Infectious diseases
Oncology or cancer
Cardiology
Nephrology
Autoimmune diseases
Drug testing
HIV or Aids
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue
1.4 Market by Type
1.4.1 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Reagents and kits
1.4.3 Instruments
1.4.4 Services
1.4.5 Data management software
1.5 Market by Application
1.5.1 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application: 2020 VS 2026
1.5.2 Diabetes
1.5.3 Infectious diseases
1.5.4 Oncology or cancer
1.5.5 Cardiology
1.5.6 Nephrology
1.5.7 Autoimmune diseases
1.5.8 Drug testing
1.5.9 HIV or Aids
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Perspective (2015-2026)
2.2 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Growth Trends by Regions
2.2.1 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Historic Market Share by Regions (2015-2020)
2.2.3 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Growth Strategy
2.3.6 Primary Interviews with Key In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Players by Market Size
3.1.1 Global Top In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Players by Revenue (2015-2020)
3.1.2 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue Market Share by Players (2015-2020)
3.1.3 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Concentration Ratio
3.2.1 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue in 2019
3.3 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players Head office and Area Served
3.4 Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Product Solution and Service
3.5 Date of Enter into In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Historic Market Size by Type (2015-2020)
4.2 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
5.2 Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
6.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in North America (2019-2020)
6.3 North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
6.4 North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
7.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in Europe (2019-2020)
7.3 Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
7.4 Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
8 China
8.1 China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
8.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in China (2019-2020)
8.3 China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
8.4 China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
9 Japan
9.1 Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
9.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in Japan (2019-2020)
9.3 Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
9.4 Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
10.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
10.4 Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
11 India
11.1 India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
11.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in India (2019-2020)
11.3 India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
11.4 India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size (2015-2020)
12.2 In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Players in Central & South America (2019-2020)
12.3 Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020)
12.4 Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Roche Diagnostics
13.1.1 Abbott Roche Diagnostics Company Details
13.1.2 Abbott Roche Diagnostics Business Overview
13.1.3 Abbott Roche Diagnostics In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Introduction
13.1.4 Abbott Roche Diagnostics Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020))
13.1.5 Abbott Roche Diagnostics Recent Development
13.2 Siemens Healthcare GmbH
13.2.1 Siemens Healthcare GmbH Company Details
13.2.2 Siemens Healthcare GmbH Business Overview
13.2.3 Siemens Healthcare GmbH In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Introduction
13.2.4 Siemens Healthcare GmbH Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020)
13.2.5 Siemens Healthcare GmbH Recent Development
13.3 SQI Diagnostics
13.3.1 SQI Diagnostics Company Details
13.3.2 SQI Diagnostics Business Overview
13.3.3 SQI Diagnostics In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Introduction
13.3.4 SQI Diagnostics Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020)
13.3.5 SQI Diagnostics Recent Development
13.4 Bio-Rad Laboratories Inc.
13.4.1 Bio-Rad Laboratories Inc. Company Details
13.4.2 Bio-Rad Laboratories Inc. Business Overview
13.4.3 Bio-Rad Laboratories Inc. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Introduction
13.4.4 Bio-Rad Laboratories Inc. Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020)
13.4.5 Bio-Rad Laboratories Inc. Recent Development
13.5 Omega Diagnostics Group PLC
13.5.1 Omega Diagnostics Group PLC Company Details
13.5.2 Omega Diagnostics Group PLC Business Overview
13.5.3 Omega Diagnostics Group PLC In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Introduction
13.5.4 Omega Diagnostics Group PLC Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020)
13.5.5 Omega Diagnostics Group PLC Recent Development
13.6 Beckton Dickinson & Company
13.6.1 Beckton Dickinson & Company Company Details
13.6.2 Beckton Dickinson & Company Business Overview
13.6.3 Beckton Dickinson & Company In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Introduction
13.6.4 Beckton Dickinson & Company Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020)
13.6.5 Beckton Dickinson & Company Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Key Market Segments
Table 2. Key Players Covered: Ranking by In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue
Table 3. Ranking of Global Top In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Reagents and kits
Table 6. Key Players of Instruments
Table 7. Key Players of Services
Table 8. Key Players of Data management software
Table 9. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Regions (2015-2020)
Table 13. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Growth Strategy
Table 19. Main Points Interviewed from Key In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Players
Table 20. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue by Players (2015-2020) (Million US$)
Table 21. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Players (2015-2020)
Table 22. Global Top In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases as of 2019)
Table 23. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Product Solution and Service
Table 26. Date of Enter into In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 29. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size Share by Type (2015-2020)
Table 30. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue Market Share by Type (2021-2026)
Table 31. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size Share by Application (2015-2020)
Table 32. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 33. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size Share by Application (2021-2026)
Table 34. North America Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 35. North America Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 36. North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 37. North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 38. North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 39. North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 40. Europe Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 42. Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 43. Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 44. Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 45. Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 46. China Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 47. China Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 48. China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 49. China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 50. China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 51. China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 52. Japan Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 54. Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 55. Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 56. Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 57. Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 60. Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 62. Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 64. India Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 65. India Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 66. India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 67. India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 68. India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 69. India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 70. Central & South America Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (2019-2020)
Table 72. Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type (2015-2020)
Table 74. Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application (2015-2020)
Table 76. Abbott Roche Diagnostics Company Details
Table 77. Abbott Roche Diagnostics Business Overview
Table 78. Abbott Roche Diagnostics Product
Table 79. Abbott Roche Diagnostics Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020) (Million US$)
Table 80. Abbott Roche Diagnostics Recent Development
Table 81. Siemens Healthcare GmbH Company Details
Table 82. Siemens Healthcare GmbH Business Overview
Table 83. Siemens Healthcare GmbH Product
Table 84. Siemens Healthcare GmbH Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020) (Million US$)
Table 85. Siemens Healthcare GmbH Recent Development
Table 86. SQI Diagnostics Company Details
Table 87. SQI Diagnostics Business Overview
Table 88. SQI Diagnostics Product
Table 89. SQI Diagnostics Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020) (Million US$)
Table 90. SQI Diagnostics Recent Development
Table 91. Bio-Rad Laboratories Inc. Company Details
Table 92. Bio-Rad Laboratories Inc. Business Overview
Table 93. Bio-Rad Laboratories Inc. Product
Table 94. Bio-Rad Laboratories Inc. Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020) (Million US$)
Table 95. Bio-Rad Laboratories Inc. Recent Development
Table 96. Omega Diagnostics Group PLC Company Details
Table 97. Omega Diagnostics Group PLC Business Overview
Table 98. Omega Diagnostics Group PLC Product
Table 99. Omega Diagnostics Group PLC Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020) (Million US$)
Table 100. Omega Diagnostics Group PLC Recent Development
Table 101. Beckton Dickinson & Company Company Details
Table 102. Beckton Dickinson & Company Business Overview
Table 103. Beckton Dickinson & Company Product
Table 104. Beckton Dickinson & Company Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Business (2015-2020) (Million US$)
Table 105. Beckton Dickinson & Company Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Type: 2020 VS 2026
Figure 2. Reagents and kits Features
Figure 3. Instruments Features
Figure 4. Services Features
Figure 5. Data management software Features
Figure 6. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Application: 2020 VS 2026
Figure 7. Diabetes Case Studies
Figure 8. Infectious diseases Case Studies
Figure 9. Oncology or cancer Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Nephrology Case Studies
Figure 12. Autoimmune diseases Case Studies
Figure 13. Drug testing Case Studies
Figure 14. HIV or Aids Case Studies
Figure 15. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Report Years Considered
Figure 16. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Regions: 2020 VS 2026
Figure 18. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share by Players in 2019
Figure 21. Global Top In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases as of 2019
Figure 22. The Top 10 and 5 Players Market Share by In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue in 2019
Figure 23. North America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
体外診断（IVD）の世界市場（～2026年） Market Analysis and Insights: Global In Vitro Diagnostics (IVD) Market The global In Vitro Diagnostics (IVD) market size is projected to reach US$ 82390 million by 2026, from US$ 76910 million in 2020, at a CAGR of 6.6%% during 2021-2026. Global In Vitro Diagnostics (IVD) Scope and Market Size In Vi…- 体外診断（IVD）パッケージングの世界市場（～2026年） In vitro diagnostic instruments are instruments that intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparatio…
- 体外診断（IVD）品質管理の世界市場（～2026年） Related products that used to control quality of In Vitro Diagnostics. The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the quality control market. Market Analysis and Insights: …
- 臨床検査の世界市場（～2026年） Clinical laboratory test is a generic term for any test regarded as having value in assessing health or disease states. Owing to the increase in aging population and long-term healthcare needs, the clinical laboratory test market is expected to grow rapidly over the forecast period. Market Analysis …
- IVD（体外診断）検査の世界市場（～2026年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…